115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39029)
  2. GSK Faculty (22465)
  3. Solid Tumor Oncology Division (22054)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12607)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39029)
  2. GSK Faculty (22465)
  3. Solid Tumor Oncology Division (22054)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1227)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports
    Meeting Abstract

    Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A bird's-eye view of disparity from public historic cancer mortality data in the US: Advocacy for gastrointestinal cancers and for inter-agency data harmonization
    Meeting Abstract

    Zhang, T.; Hung, T.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes
    Meeting Abstract

    Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Meeting Abstract

    Mai, N.; Safonov, A.; Marra, A.; Chen, Y.; Chandarlapaty, S.; Razavi, P.; Plitas, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Evaluating antitumor activity and response determinants to trastuzumab deruxtecan in pediatric solid tumors
    Meeting Abstract

    Burke, C.; Ferreira Ferreira Coutinho, D.; Ibanez, G.; You, D.; Ndengu, A. A.; Calder, P.; Guillan, K.; Siddiquee, A.; Rosales, N.; Long, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas: Results of a prospective pilot study
    Meeting Abstract

    Offin, M.; Lavin, Y.; Zatzman, M.; Sauter, J. L.; Ceglia, N.; Travis, W. D.; Aly, R. G.; Rimner, A.; Shepherd, A.; Simone, C. B. 2nd; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Induction chemotherapy effects on very advanced (T3/T4) human papillomavirus-related oropharyngeal cancer for participation in hypoxia-directed major deescalation (30 Gy) definitive treatment trial
    Meeting Abstract

    Sherman, E. J.; Riaz, N.; Dunn, L.; Schòˆder, H.; Wray, R.; Ganly, I.; Boyle, J.; Patel, S. G.; Givi, B.; Fetten, J. V.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Yeh, C.; Harrold, E.; Keane, F.; Sinopoli, J. C.; Foote, M. B.; Cercek, A.; Yaeger, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save